E

ETRA

ETRA

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
100%Bullish
Buy/Sell Ratio100% buys
BearishBullish
ETRA Live QuoteReal-time
$8.94
$0.11(-1.22%)1M
Day Range$8.40 – $9.19
Open$8.57
Previous Close$8.43
Volume413.8K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$529.13M
P/E Ratio (TTM)24.5
Forward P/ENaN
EPS (TTM)$-35.94
Price to Book1.3
Dividend Yield0.65%
Beta (Volatility)1.18
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $8.94 (24%)
Low: $6.87High: $15.50
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$33.20-77.9% upside

Insider Buys

4

$47.21M

Insider Sales

0

$0

Total Volume

$47.21M

4 transactions

Net Activity

+$47.21M

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
90CONFIDENCE

Sentiment Rating

Strong Accumulation

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Strong buying bias: purchases represent 100% of total transaction value.
  • •Minor cluster buying: 2 unique insiders purchased shares.
  • •Ultra-high accumulation: total purchase value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
G
1

Gordon Carl L

Dir, 10%

2 buys0 sells

$23.61M total

O
2

Orbimed Advisors LLC

Dir, 10%

2 buys0 sells

$23.61M total

Trading History
ETRA insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Nov 3, 2026

2 weeks ago

Gordon Carl L

Dir, 10%

Director
Buy472.6K$7.63$3.61M

Nov 3, 2026

2 weeks ago

Orbimed Advisors LLC

Dir, 10%

Director
Buy472.6K$7.63$3.61M

Sep 21, 2026

2 months ago

Gordon Carl L

Dir, 10%

Director
Buy1.33M$15.00$20.00M

Sep 21, 2026

2 months ago

Orbimed Advisors LLC

Dir, 10%

Director
Buy1.33M$15.00$20.00M
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
ETRA Buy Conviction100%
Industry Rank#160 of 569
Volume Contribution0.3%
Total Industry Activity$16.52B

ETRA has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%. ETRA ranks #160 in insider activity out of 569 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for ETRA

Over the last 90 days, corporate insiders at ETRA (ETRA) engaged in a total of 4 transactions reported via SEC Form 4 filings. Among these, 4 were open-market purchases and 0 were sales. The total volume of insider trading reached $47.21M.

The net insider activity for ETRA shows a net buying bias of $47.21M. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Purchase by Gordon Carl L (Dir, 10%), who traded 1.33M shares valued at $20.00M on Sep 21, 2026.

Live Market News & Developments
Aggregated real-time headlines for ETRA (ETRA)
6 updates

Electra Therapeutics: A Broken IPO Leaves The SIRP Platform Nearly Free (NASDAQ:ETRA)

Seeking Alpha3d ago

symbol__ Stock Quote Price and Forecast

CNN66d ago

Electra Therapeutics, Inc. (ETRA) Stock Price Prediction for 2026, 2030-2040

Traders Union9d ago

Electra Therapeutics (ETRA) director Orbimed Advisors bought 92,116 shares for $745K at an average $8.08

Quantisnow9d ago

Two reporting persons share voting power over 3.37M Electra Therapeutics (ETRA) shares.

Stock Titan3d ago

ETRA: Electra Therapeautics Latest Stock Price, Analysis, News and Trading Ideas

Stocktwits66d ago

FAQs About ETRA Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for ETRA.

Based on SEC Form 4 disclosures, the Insider Confidence Score for ETRA is currently 90/100, which reflects a strong accumulation bias. This calculation accounts for a total of 4 purchases and 0 sales by company executives over the last 90 days.

The CEO Conviction Index for ETRA is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.